ياجماعه هذا تطبيل والا حقيقه ؟؟؟
رفع السعر المستهدف من 32 الي 38 وهو ماوصل ربع ا لسعر الان مقفل 9
حتى الخواجات عندهم هالسوالف ؟؟؟
Aldeyra Therapeutics (NASDAQ:ALDX) had its price objective raised by Citigroup from $32.00 to $38.00 in a research report released on Tuesday morning, The Fly reports. The firm currently has a positive rating on the biotechnology company’s stock.
A number of other brokerages have also recently weighed in on ALDX. BidaskClub upgraded shares of Aldeyra Therapeutics from a sell rating to a hold rating in a report on Thursday, January 10th. Zacks Investment Research upgraded shares of Aldeyra